Shionogi Co Stock Fundamentals
| SGIOF Stock | USD 12.41 0.00 0.00% |
Shionogi Co fundamentals help investors to digest information that contributes to Shionogi's financial success or failures. It also enables traders to predict the movement of Shionogi Pink Sheet. The fundamental analysis module provides a way to measure Shionogi's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shionogi pink sheet.
Shionogi |
Shionogi Co Company Return On Equity Analysis
Shionogi's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Shionogi Return On Equity | 0.2 |
Most of Shionogi's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shionogi Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Shionogi Co has a Return On Equity of 0.2014. This is 100.84% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 164.97% lower than that of the firm.
Shionogi Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shionogi's current stock value. Our valuation model uses many indicators to compare Shionogi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shionogi competition to find correlations between indicators driving Shionogi's intrinsic value. More Info.Shionogi Co is rated second in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shionogi Co is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shionogi's earnings, one of the primary drivers of an investment's value.Shionogi Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shionogi's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Shionogi could also be used in its relative valuation, which is a method of valuing Shionogi by comparing valuation metrics of similar companies.Shionogi is currently under evaluation in return on equity category among its peers.
Shionogi Fundamentals
| Return On Equity | 0.2 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.44 % | |||
| Operating Margin | 0.43 % | |||
| Current Valuation | 11.39 B | |||
| Shares Outstanding | 298.16 M | |||
| Shares Owned By Insiders | 4.66 % | |||
| Shares Owned By Institutions | 52.78 % | |||
| Price To Earning | 15.47 X | |||
| Price To Book | 2.01 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 335.14 B | |||
| Gross Profit | 279.72 B | |||
| EBITDA | 143.46 B | |||
| Net Income | 114.19 B | |||
| Cash And Equivalents | 502.8 B | |||
| Total Debt | 6.65 B | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 5.27 X | |||
| Book Value Per Share | 3,586 X | |||
| Cash Flow From Operations | 102.07 B | |||
| Earnings Per Share | 2.98 X | |||
| Price To Earnings To Growth | 14,289 X | |||
| Target Price | 16.97 | |||
| Number Of Employees | 5.69 K | |||
| Beta | 0.57 | |||
| Market Capitalization | 14.11 B | |||
| Total Asset | 1.15 T | |||
| Retained Earnings | 524.07 B | |||
| Working Capital | 265.13 B | |||
| Current Asset | 324.6 B | |||
| Current Liabilities | 59.48 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.57 % | |||
| Net Asset | 1.15 T | |||
| Last Dividend Paid | 120.0 |
About Shionogi Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shionogi Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shionogi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shionogi Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Shionogi Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Shionogi Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. Shionogi operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5693 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Shionogi Pink Sheet
Shionogi financial ratios help investors to determine whether Shionogi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shionogi with respect to the benefits of owning Shionogi security.